对于多发性骨髓瘤的伊克萨佐米布维持治疗中的第二次主要恶性病:病例报告和文献综述
Ying Wang1, Chun-Li Xu2,3, Dong-Ping Huang4
1Department of Hematology, The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China.
Case reports in hematology
|November 27, 2025
概括
接受ixazomib维持治疗的多发性骨髓瘤患者可能面临患二次骨髓发育不良综合征的风险增加. 需要进一步的研究来证实这一关联.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床医学 临床医学
背景情况:
- 多发性骨髓瘤 (MM) 的生存率正在改善,导致人们越来越关注长期并发症.
- 第二次原发性恶性瘤 (SPMs) 对MM幸存者来说是一个越来越令人担忧的问题.
- 了解MM继发的SPM的机制和治疗是至关重要的.
研究的目的:
- 在多发性骨髓瘤患者中报告二次骨髓质疏松综合征 (MDS) 的病例.
- 调查ixazomib维持疗法与SPM发展之间的潜在关联.
主要方法:
- 病例报告详细介绍了一位患有MM的患者,后来患上了MDS.
- 审查患者的治疗史,包括5年的ixazomib维持化疗.
主要成果:
- 一位年轻的MM患者在接受了ixazomib维持治疗5年后发展出了MDS.
- 该患者接受了全基血造干细胞移植 (allo-HSCT) 并且目前还活着.
结论:
- 艾克萨佐米布维持治疗后的MDS的发展需要进一步的研究.
- 不能排除ixazomib与增加SPM风险之间的潜在联系.
- 需要进行更大规模的研究来验证这些发现.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.4K
09:43Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
8.4K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
